Intravoxel incoherent motion (IVIM) imaging is increasingly applied in the assessment of head and neck cancer (HNC). Our purpose was to determine the diagnostic and prognostic performance of IVIM in HNC by performing a critical review of the literature. Pubmed and EMBASE were searched until May 2016. Study and patient characteristics, imaging protocol and diagnostic or prognostic outcomes were extracted by two independent reviewers. The studied IVIM parameters were diffusion coefficient (D), pseudodiffusion coefficient (D*), and perfusion fraction (f). We included 10 diagnostic studies, five prognostic studies and two studies assessing both. Studies were very heterogeneous in terms of applied b-values, imaging protocols, outcome measurements and reference standards; therefore, we did not perform a meta-analysis. The most commonly used sequence was "spin-echo planar imaging". A median of 10.5 b-values (range, 3-17) were used. All but three studies included at least four b-values below b=200 s/mm 2 . By combining IVIM-parameters squamous cell carcinomas, lymphomas, malignant salivary gland tumors, Warthin's tumors and pleomorphic adenomas could be differentiated with a sensitivity of 85-87% and specificity of 80-100%. Low pre-treatment D or f and an increase in D during treatment were associated with a favorable response to treatment. D* appeared to be the parameter with the lowest prognostic value. Future research should focus on finding the optimal IVIM protocol, using uniformly accepted study methods and larger patient populations.
INTRODUCTION
Head and neck cancer (HNC) accounts for approximately 4% of the cancer case worldwide, making HNC the sixth most common cancer by incidence rate (1, 2) . HNC mainly consists of tumors arising in the oral cavity, nasopharynx, oropharynx, hypopharynx, larynx and salivary glands.
Squamous cell carcinomas (SCC) account for over 90% of HNC (3) . Alcohol and tobacco use are the most important risk factors (4) . While early stage disease is usually treated by surgery or radiotherapy, advanced stage disease is generally treated by surgery and adjuvant radiotherapy with or without chemotherapy or combined chemotherapy and radiotherapy. Salvage surgery is then held in reserve for residual or recurrent disease (2, (5) (6) (7) . While chemotherapy is mainly used in a concomitant setting with radiotherapy, in selected cases it can also be applied as neoadjuvant treatment (2) . There is increasing evidence that in some geographic regions up to 80% of the oropharyngeal SCC is associated with the human papillomavirus (HPV), especially in relatively young patients who do not drink or smoke (8) . Oropharyngeal SCC associated with HPV has a different tumor biology and is associated with a better prognosis than HPV-negative SCC (5) (6) (7) . Therefore, it is proposed to de-escalate treatment in HPV-associated oropharyngeal SCC in patients who do not smoke.
Nasopharyngeal carcinoma (NPC) takes a unique place in epithelial HNC because of the very distinct geographical distribution ranging from 1:100.000 in Western Europe to >20:100.000 in parts of Southeast Asia (2, 9) . Further it harbors an association with the Epstein-Barr virus (EBV) which is not seen in other HNC (9) . Nasopharyngeal carcinoma has a different tumor biology as compared to other HNC.
Imaging is increasingly used for diagnosing and staging of HNC, monitoring the effect of treatment and in the detection of distant metastases and recurrent disease (10) (11) (12) . In this systematic review we focus on the use of intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) for diagnosis in HNC.
In general, water diffusion is restricted in malignant tissue. With diffusion-weighted imaging (DWI) this restricted diffusion can be imaged and quantified. The main advantage of DWI compared to other functional imaging techniques (e.g. dynamic contrast-enhanced MRI and positron emission tomography) is that it requires neither the administration of contrast medium or radioactive tracer nor the use of ionizing radiation.
One of the proposed methods to quantify diffusion is by considering diffusion as a monoexponential phenomenon. In this way diffusion can be quantified in an apparent diffusion coefficient (ADC) (13) . The word "apparent" implicates that in this way true diffusion is not measured. Especially at low b-values other parameters as blood volume and blood flow also contribute to the ADC (14, 15) . The ADC concept provides a quantifiable measure with promising results in HNC, e.g. in discriminating metastatic from benign lymph nodes with an accuracy of >85% and in the detection of recurrent disease with an accuracy of >78% (16) .
The signal decay after the diffusion-encoding gradients is not only caused by diffusion, but also by pseudorandom, or "incoherent", perfusion at the capillary level. To account for this, Le Bihan et al. introduced the bi-exponential IVIM model (13) : Where S b represents the signal intensity with diffusion gradient b, and S 0 represents the signal intensity without diffusion gradients. D is known as pure or slow diffusion coefficient which is related to pure molecular diffusion. D* is the fast or pseudodiffusion coefficient that resembles the perfusion related incoherent microcirculation and is about a factor of 10 greater than D in biological tissue (13) . Finally, f is the perfusion or (micro)vascular volume fraction which depends on capillary geometry and blood velocity (13) . In this way pure tissue diffusion may be quantified and also perfusion characteristics may be assessed without the admission of contrast-material. Commonly D is first estimated using a linear fit using only high b-values (i.e., above 200 s/mm 2 (17) ) and then f and D* are calculated using a non-linear least-squares algorithm.
With IVIM being increasingly used in HNC, a critical systematic review of the diagnostic and prognostic value of this technique is warranted. The purpose of this study was therefore to determine the diagnostic and prognostic performance of IVIM in HNC. Histopathology, other imaging modalities or clinical follow-up were used as reference standards.
METHODS AND MATERIALS
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for systematic reviews and meta-analyses was used as a guidance (18) .
Search strategy
This systematic search was conducted in Pubmed and Embase until May 2016 for original articles on the diagnostic and/or prognostic capability of IVIM in HNC. We did not apply language restrictions. We approached corresponding authors for additional data if necessary (e.g. to compute sensitivity and specificity). The only included search terms were "(IVIM OR ((intra-voxel OR intravoxel) AND incoherent AND motion))" in order to be as sensitive as possible. In the Pubmed search we used text words [tw] in the absence of MeSH-terms on this subject.
Two authors (DPN and RMM) independently selected relevant articles based on title and abstracts and discrepancies were resolved by consensus.
The inclusion criteria were: 1) The study population consisted of at least 10 patients with malignant lesions in the head and neck area; 2) The study assessed diagnosing malignancy, response prediction to therapy, detection of residual/ recurrent disease. Or data of these subjects could be extracted from the article; 3) Histopathology, clinical follow-up or another imaging modality was used as reference standard test. Exclusion criteria were: 1) The publication was a review, meta-analysis, only published as abstract or if it was another non-primary publication (e.g. editorial, technical note); 2) The study reported on (potentially) overlapping study populations.
Data extraction
Data on the study and patient characteristics, the imaging protocol and diagnostic outcomes were extracted by two independent reviewers (DPN and RMM) and discrepancies were resolved by consensus. If available, source data (i.e. true positive (TP), false positive (FP), true negative (TN), and false negative (FN)) were extracted or recalculated. If unavailable, the corresponding author of the article was contacted to provide additional data.
Quality assessment
Two authors (DPN and RMM) independently assessed all studies for study quality and discrepancies were resolved by consensus. All included studies were assessed for quality by using the QUality Assessment of studies of Diagnostic Accuracy included in Systematic reviews (QUADAS-2) checklist (19) . The quality of prognostic studies was also assessed with the QUality In Prognostic Studies (QUIPS) checklist (20, 21) .
Statistical analysis
Diagnostic accuracy data is presented with 95% confidence intervals (95%CI) if presented by the authors, or when we were able to reconstruct a 2x2 table. Receiver operating characteristic (ROC) analysis was performed if per-patient data could be extracted using SPSS Statistics (version 20.0; Chicago, IL, USA). The Youden Index (YI) was used to determine the optimal cut-off. P-values were reported as NS (not statistically significant, i.e., P≥0.05), ≤0.05, ≤0.01, and ≤0.001.
RESULTS
The search in Pubmed and Embase retrieved 429 unique studies. After excluding 383 studies on title or abstract we reviewed the full text of 46 studies. Finally, 17 studies were included (10 diagnostic, 5 prognostic and 2 both) for qualitative analysis (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (Figure 1 ). Due to heterogeneity in applied b-values, imaging protocols, outcome measurements and reference standards we decided not to perform any quantitative meta-analysis. ArƟcles included in qualitaƟve synthesis n=17
Exclusion based on Ɵtle and/or abstract n=384
Exclusion based on full text n=29
Removal of duplicates n= 290
Unique arƟcles n=430
Reasons for full text exclusion:
•≤10 paƟents with HNSCC in the study populaƟon (n=18)
•The study does not assess the diagnosƟc or prognosƟc performance of IVIM (n=5)
•No reference standard of the outcome measurement (n=1)
•Review, meta-analysis or conference abstract (n=3)
•PotenƟally overlapping study populaƟons (n=2)
Figure 1 Flow chart of study inclusion

Study characteristics
In total the selected studies included 882 patients (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . The most common included head and neck malignancies were nasopharyngeal carcinoma (n=417) and squamous cell carcinoma at other sites (n=220 /s) and f (n=130, mean=22.3%). These differences where significant (P<0.001 for D and D* and P=0.006 for f).
Imaging was performed at 1.5 T in nine studies) (22, 29-34, 36, 37) or 3 T in eight (23, 25-28, 36, 38) (24) . Diffusion-weighted imaging was commonly performed with single-shot spin-echo echo planar imaging (SS-SE-EPI) (n=13) (23) (24) (25) (26) (27) (28) (29) (30) (32) (33) (34) (35) (36) (37) (38) . In four of these studies the use of fat saturation is mentioned with CHEmical Shift Selective (CHESS) (31), chemical shift-based fat suppression (23) or Spectral Presaturation with Inversion Recovery (SPIR) (27, 28) . One study used short tau inversion recovery EPI (STIR-EPI) (22) and another study used Half-fourier acquisition single-shot turbo spin-echo (HASTE) (31) . Diffusionweighted imaging was acquired with a median of 10.5 b-values (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] (17) ) is important for bi-exponential fitting of the signal intensity over b. One study did only include b=0 s/mm 2 as b-value below b=200 s/mm 2 (33) . Another study did include three b-values below b=200 s/mm 2 (22) . The other studies included a median of seven b-values below b=200 s/mm 2 (range, 4-11) (23, 25-32, 34-36, 38) . The LevenbergMarquardt algorithm was most commonly used for signal fitting (n=11) (25-28, 31, 34-36, 38) . In 12 studies it was mentioned that a two-step-fit was used with an estimation of D in the first step with D* and f being determined in the second step (23, 24, 26, (30) (31) (32) (33) (34) (35) (36) (37) (38) . Median scan time was 4:51 minutes (range, 01:30-12:00 minutes). An overview of imaging characteristics is mentioned in Table 2 . 
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Quality assessment
Results of QUADAS-2 and QUIPS are mentioned in Table 3 and 4.
The QUADAS-2 yielded the following findings. There was a high risk of a biased patient selection in six studies (22, 24, 26, 27, 29, 32) . In two studies this was due to a casecontrol design (22, 27) . In six studies there were inappropriate exclusions (22, 24, 26, 27, 29, 32) . For example by classifying lymph node as benign or malignant based only on imaging criteria, which may result in missing small lymph node metastases (26); by only including patients with lymph node metastases when the primary tumor is assessed separately, while patients with an N0 neck could have been included as well (24, 29) ; or by only including patients of whom the tumor was excised, while also including biopsy-proven malignancies would have led to a larger patient population (32) . In none of the 10 studies where a threshold was used this was pre-specified, which may result in an overestimation of diagnostic value (23, 24, 28, 29, 31, (34) (35) (36) (37) (38) . In two studies the observers were not blinded to the reference standard (29, 30) and in 11 studies this was unclear (22, 24-28, 32-34, 37, 38) . In five studies imaging was used as reference standard instead of histopathology (22, 23, 25, 35, 36) . The interval between index test and reference standard was not mentioned in 10 studies (22, (27) (28) (29) (30) (31) (32) (33) (34) 36) .
For the prognostic studies the assessment with QUIPS yielded the following results. In four studies reasons for loss to follow-up are mentioned without describing participants who were lost to follow-up (23, 25, 26, 36) . Xiao et al. excluded patients with insufficient followup images (35) . None of the included studies attempted to correct for possible confounders (23-26, 29, 35, 36) . Lu et al. used both parametric and non-parametric statistical tests on the same data which raised concerns on the adequacy of the statistical analysis (29) .
In three studies we were unable to reconstruct a two-by-two table based on the given sensitivity and specificity (24, 35, 36) .
Diagnostic study results
Study results are mentioned in Table 5 and Appendix B. In 9 studies the primary tumor was assessed separately (24, 27, 28, 30-32, 34, 37, 38) , in two studies lymph nodes were assessed separately (22, 28) and in four studies a combination of primary tumor and lymph nodes was assessed (28, 29, 32, 33) . 
the authors used another symbol; GeoP is more weighted to the extravascular space compared to D* which is more weighted towards the vascular space. Based on the data provided in the appendix we used ROC analysis to determine the diagnostic accuracy of IVIM (with both methods) to discriminate SCC from lymphoma as these were the most prevalent malignancies in this study (32) . Table 5 Diagnostic accuracy Table 5 continued n Parameter Outcome measurement
Cut-off Sensitivity (95%CI) Specificity (95%CI) AUC (95%CI)
Sumi ( Warthin tumors (P≤0.01). These results were verified in two other studies (32, 34 Two studies assessed the difference of IVIM parameters between primary SCC and lymph nodes. Lu et al. (29) showed that lymph nodes have significantly higher D values (P≤0.001) and lower f values (P≤0.001). These results could not be confirmed by Sasaki et al. (32) who did not find any significant differences between primary SCC and SCC lymph nodes. It should be noted that in the first study included patients all had a primary tumor and a lymph node metastasis; whereas in the second study it is not specified whether primary tumors and lymph node metastasis of the same patients were assessed.
The differentiation between malignant tumor and post-chemoradiation fibrosis was assessed by Lai et al. (27) in a case-control study including pre-treatment NPC and biopsyconfirmed post-chemoradiation fibrosis. With D it was possible to separate both with a sensitivity (95%CI=93-100%) and specificity (95%CI=88-100%) of 100%.
In another study by Lai et al. (28) NPC at different disease stages were compared. For T stage, N stage and disease stage according to the American Joint Committee on Cancer (AJCC), all IVIM parameters (i.e., D, D* and f) were significantly lower in the high stage group than in the low stage group. For N staging and AJCC staging, D had the highest diagnostic accuracy (AUC=0.86 and 0.91, respectively), while f had the highest AUC in T staging (AUC=0.90). In multivariate analysis there was a non-significant trend towards a higher AUC for the combined use of all IVIM parameters. Dikaios et al. (22) used a (conventional) non-linear (NR) and a maximum probability (MP) model to estimate IVIM-parameters for differentiating between benign and malignant lymph nodes. No significant differences between models were found. Both f and D* were significantly different (P≤0.01) between benign and malignant nodes while D was not.
Prognostic study results
Prognostic study results are mentioned in Table 6 and Appendix C. In five studies the primary tumor was assessed (23-25, 29, 35, 36) separately, in three studies lymph nodes were assessed separately (23, 26, 35) and in one both were assessed simultaneously (23) .
The value of IVIM in predicting response to neo-adjuvant chemotherapy (NAC) in NPC was assessed by Xiao et al. (35) and Xiao-Ping et al. (36) . In both studies pre-treatment D could significantly predict the response to NAC (P≤0.01) with a sensitivity and specificity of 64-65% and 72-81%, respectively. In both studies f was a weaker predictor than D, with only Δf being a significant predictor in the study of Xiao et al (primary tumor: P≤0.05; lymph node: P ≤0.01) (35).
Table 6
Prognostic accuracy In the study of Xiao-Ping et al. sensitivity increased to 94% and specificity was 77% when the difference in D before and after NAC was used to assess the effect of NAC (36) . It should be noted that pre-NAC D had a relatively high diagnostic accuracy in predicting the presence of residual disease after chemoradiotherapy with a sensitivity of 82% and a specificity of 83%. Ding et al. performed IVIM before and during chemoradiotherapy in HPV-positive primary HNSCC and found pre-treatment D to differ significantly between responders and non-responders (23). Guo et al. found similar results in predicting treatment response in NAC for hypopharyngeal SCC with D being the strongest predictor with a sensitivity of 75% and specificity being 89% (24) .
These findings are in contrast to Hauser et al. who performed one study on primary tumors (25) and one on lymph nodes (26) . The patient population consisted of HNSCC patients receiving chemoradiotherapy. In both studies, pretreatment f discriminated best between responders and non-responders (P≤0.01), whereas D was not statically significant.
To conclude it should be noted that in only one of the prognostic studies D* differed statistically significantly between responders and non-responders (24) .
DISCUSSION
In studies on patients with SG tumors, all IVIM values of malignant SG tumors were between those of Warthin tumors and pleomorphic adenomas (32) (33) (34) . This demonstrates that diagnostic accuracy of IVIM in distinguishing between malignant and benign head and neck lesions depends strongly on the included tumor types. With IVIM it was possible to reliably differentiate between SCCs, lymphomas, malignant SG tumors, Warthin tumors and pleomorphic adenomas (31, 33, 34, 37) . It should be noted that combining IVIM parameters often yielded a higher diagnostic accuracy than using a single IVIM parameter (22, 28, 29, 31, 32, 34, 37) . Future research should focus on finding the optimal combination of functional imaging parameters, for example by combining IVIM with dynamic contrast-enhanced MRI (39) . Preferably only lesions should be included which are currently challenging to separate.
Detection of residual disease in irradiated tissue remains challenging (40) . A recent randomized trial did reveal that 18 F-FDG-PET-CT can reduce the need for investigations under anesthesia after RT for laryngeal carcinoma without compromising treatment quality (41) . Especially early after (chemo)radiotherapy inflammation may result in residual 18 F-FDG uptake. Combined with a relatively low prevalence of residual disease this results in a relatively poor positive predictive value (PPV) of PET-CT, which leaves room for improvement (40) . Performing additional IVIM imaging may enhance the PPV of 18 F-FDG-PET-CT. Lai et al. (27) showed that pretreatment NPC could be separated from posttreatment fibrosis with an accuracy of 100%. In practice residual tumor foci may be hidden in fibrotic tissue and therefore may be more challenging to detect. Further research should assess if the resolution of IVIM imaging is appropriate to detect residual disease in the proximity to fibrosis with a high diagnostic accuracy. In order to identify the most optimal timing of IVIM imaging after irradiation more research is necessary. Preferably by performing IVIM multiple times during and after radiation therapy. Besides individual IVIM values, it may also be valuable to look at Δ values between different time points. In the studies included in this systematic review follow-up was relatively short, with a maximum of 3 months (23, 24) , in the studies where intra-or posttreatment imaging was performed. In only one of the prognostic studies D* was significantly different between responders and non-responders suggesting that this parameter has the least potential to predict prognosis (24) . There is less consensus on the prognostically most promising parameter. In four studies D had the highest predictive value (23, 24, 35, 36) and in two studies f was the strongest predictor of treatment outcome (25, 26) .
A proposed hypothesis is that high f is associated with a higher regional blood flow (15) . High regional blood flow may be indicative of a high microvessel density which is associated with a higher likelihood of both lymph node and distant metastases (42) . Therefore high f could be an unfavorable prognostic factor for survival. D appears to be inversely correlated with cell density (43, 44) . Highly cellular tumors with rapidly dividing cells are more sensitive to chemotherapy and radiotherapy and therefore associated with a more favorable prognosis (23, 24, 35, 36) . An increase in D during therapy is therefore a sign of decreasing cellularity and a good response to treatment (23, 24, 35, 36) .
Lai et al. (28) showed that IVIM values differed between disease stages (AJCC, T stage and N stage). Tumors with a high cell turnover with more cell division may result in a larger tumor with densely packed cells resulting in both a higher disease stage and lower D values. For more perfusion weighted parameters (D* and f) it can be hypothesized that larger tumors are more prone to intratumoral necrosis due to lacking vascularization in the central portion of the tumor and therefore lower D* and f values. This is may have implications for future prognostic studies, because it warrants the need for correcting for disease stage when assessing the prognostic value of IVIM in HNC.
Imaging protocol
The optimal combination and number of b-values remains one of the keys points which need to be addressed. Lemke et al. (45) In none of the included studies imaging was performed on both a 1.5 T and 3 T MRI system on the same patients. Therefore, we could not determine whether the field strength matters for IVIM in head and neck imaging. We do consider this to be an important issue for further research. If 1.5 T and 3 T IVIM data prove to be comparable this would create more opportunities for multicenter research. In abdominal imaging there is some evidence suggesting that D and f values of the liver are reproducible on both 1.5 T and 3 T, whereas D* values are more variable (47) . However, at this moment DWI values are not considered to be robust enough to be interchangeable between institutions, regardless of field strength (48) .
In the head and neck area Sasaki et al. compared the traditional least-squares method requiring 11 b-values with a geometric approach requiring only three b-values for differentiating between tumor types (32) . Even though D values were significantly higher and f values significantly lower with the geometric approach compared to the least-squares method; diagnostic accuracy was comparable for differentiating SCC from lymphoma and characterizing SG tumors.
We recommend to include at least four b-values below b=200 s/mm 2 in order to appropriately fit estimated perfusion-related parameters (i.e. D*, f, P and PP) until a proposed method which requires fewer b-values is appropriately validated (45) . Two of the included studies did not fulfill this criterion (22, 33) . The reported D*, f and PP values of these studies should therefore be interpreted with caution. Therefore, future research should focus on the optimal combination of b-values as well as on the optimal model for determining IVIM parameters. Especially for fitting D* and f with IVIM it is important that imaging is performed with a high signal-to-noise ratio to avoid biased parameters (22) . Furthermore it should be noted that the b-value represents the strength of the diffusion pulse and is dependent of the used gradient pulse sequence, the gradient pulse duration and the gradient strength (49) . It is therefore possible to create identical b-values with different imaging parameters which may result in differences in ADC values (50 (27, 28, 37, 38) .
Limitations
Even though this review provides an extensive overview of the use of IVIM imaging in HNC, there are some limitations. Firstly, the included studies were heterogeneous in applied b-values, imaging protocols, tumor types and outcome measurements. This prevented us from performing any meaningful meta-analysis. The differences in selection and number of b-values in the lower range may compromise the comparability of results. Secondly, the relatively small population size comprised the analysis of confounders in the prognostic studies. The outcome parameters, mainly in prognostic studies, were also heterogeneous. It would be preferable if all prognostic studies reported at least one uniform outcome measurement. Even if this standard may not be a perfect gold standard, for example the RECIST criteria (51) . Thirdly, most studies did not correct for multiple testing which may overestimate the number of significant findings. Given that most studies are relatively small and that all can be regarded as positive studies it is likely that publication bias is present. Small studies with negative results may have been regarded to be not interesting enough for publication. The heterogeneity of the included studies, especially in terms of comparisons made and outcome measurements, made it impossible to perform statistical testing for the presence of publication bias.
Conclusions
With this systematic review we provide an overview of studies on IVIM in HNC. Studies are very heterogeneous in terms of applied b-values, imaging protocols, outcome measurements and reference standards. With combinations of IVIM-parameters SCC, lymphoma, malignant SG tumors, Warthin tumors and pleiomorphic adenoma can be reliably separated from each other. Low pre-treatment D and f and an increase in D during treatment was associated with a favorable response to treatment. D* appears to be the parameter with the lowest prognostic value. Future research should focus on finding the optimal IVIM protocol. When assessing diagnostic and prognostic properties of IVIM, authors should use uniformly accepted study methods and larger patient populations.
